Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Job Harenberg

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Internal and Emergency Medicine|July 31, 2017
Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysisClaudio Cimminiello, Paolo Prandoni, Giancarlo Agnelli, et al.
Seminars in Thrombosis and Hemostasis|February 24, 2015
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preferenceShabnam Zolfaghari, Job Harenberg, Lutz Frölich, et al.
Clinical Pharmacokinetics|February 12, 2025
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of ObesityDanilo Menichelli, Arianna Pannunzio, Erminia Baldacci, et al.
Thrombosis and Haemostasis|July 31, 2003
Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosisHanno Riess, Klaus Koppenhagen, Alexander Tolle, et al.
Thrombosis and Haemostasis|January 28, 2022
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in CirculationSandra Margetić, Ivana Ćelap, Arijana Lovrenčić Huzjan, et al.
Thrombosis and Haemostasis|July 5, 2022
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy StudyAnne E Merrelaar, Magdalena S Bögl, Nina Buchtele, et al.
Stroke|November 25, 2005
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT TrialHans-Christoph Diener, Erich B Ringelstein, Rüdiger von Kummer, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulationPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Clinical Pharmacokinetics|March 23, 2013
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic modelKhaled Abduljalil, Simone Lazar, Michael Natanzon, et al.
Thrombosis and Haemostasis|December 8, 2007
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant womenRupert M Bauersachs, Joachim Dudenhausen, Andree Faridi, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Internal and Emergency Medicine|July 31, 2017
Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysisClaudio Cimminiello, Paolo Prandoni, Giancarlo Agnelli, et al.
Seminars in Thrombosis and Hemostasis|February 24, 2015
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preferenceShabnam Zolfaghari, Job Harenberg, Lutz Frölich, et al.
Clinical Pharmacokinetics|February 12, 2025
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of ObesityDanilo Menichelli, Arianna Pannunzio, Erminia Baldacci, et al.
Thrombosis and Haemostasis|July 31, 2003
Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosisHanno Riess, Klaus Koppenhagen, Alexander Tolle, et al.
Thrombosis and Haemostasis|January 28, 2022
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in CirculationSandra Margetić, Ivana Ćelap, Arijana Lovrenčić Huzjan, et al.
Thrombosis and Haemostasis|July 5, 2022
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy StudyAnne E Merrelaar, Magdalena S Bögl, Nina Buchtele, et al.
Stroke|November 25, 2005
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT TrialHans-Christoph Diener, Erich B Ringelstein, Rüdiger von Kummer, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulationPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Clinical Pharmacokinetics|March 23, 2013
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic modelKhaled Abduljalil, Simone Lazar, Michael Natanzon, et al.
Thrombosis and Haemostasis|December 8, 2007
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant womenRupert M Bauersachs, Joachim Dudenhausen, Andree Faridi, et al.
Pageof 11